Skip to main content

Advertisement

Log in

Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Rapid CD4+ lymphocyte depletion due to cell death caused by HIV infection is one of the hallmarks of acquired immunodeficiency syndrome. HIV-1 viral protein R (Vpr) induces apoptosis and is believed to contribute to CD4+ lymphocyte depletion. Thus, identification of cellular factors that potentially counteract this detrimental viral effect will not only help us to understand the molecular action of Vpr but also to design future antiviral therapies. In this report, we describe identification of elongation factor 2 (EF2) as such a cellular factor. Specifically, EF2 protein level is responsive to vpr gene expression; it is able to suppress Vpr-induced apoptosis when it is overproduced beyond its physiological level. EF2 was initially identified through a genome-wide multicopy suppressor search for Vpr-induced apoptosis in a fission yeast model system. Overproduction of fission yeast Ef2 completely abolishes Vpr-induced cell killing in fission yeast. Similarly, overexpression of the human homologue of yeast Ef2 in a neuroblastoma SKN-SH cell line and two CD4+ H9 and CEM-SS T-cell lines also blocked Vpr-induced apoptosis. The anti-apoptotic property of EF2 is demonstrated by its ability to suppress caspase 9 and caspase 3-mediated apoptosis induced by Vpr. In addition, it also reduces cytochrome c release induced by Vpr, staurosporine and TNFα. The fact that overproduction of EF2 blocks Vpr-induced cell death both in fission yeast and human cells, suggested that EF2 posses a highly conserved anti-apoptotic activity. Moreover, the responsive elevation of EF2 to Vpr suggests a possible host innate antiviral response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Azad AA. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?. Biochem Biophys Res Commun 2000; 267(3): 677–685.

    Article  CAS  PubMed  Google Scholar 

  2. Bukrinsky M, Adzhubei A. Viral protein R of HIV-1. Rev Med Virol 1999; 9(1): 39–49.

    Article  CAS  PubMed  Google Scholar 

  3. Emerman M. HIV-1, Vpr and the cell cycle. Curr Biol 1996; 6(9): 1096–1103.

    Article  CAS  PubMed  Google Scholar 

  4. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3(11): E255–E263.

    Article  CAS  PubMed  Google Scholar 

  5. Talapatra S, Thompson CB. Growth factor signaling in cell survival: implications for cancer treatment. J Pharmacol Exp Ther 2001; 298(3): 873–878.

    CAS  PubMed  Google Scholar 

  6. Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002; 7(4): 313–319.

    Article  CAS  PubMed  Google Scholar 

  7. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269–290.

    Article  CAS  PubMed  Google Scholar 

  8. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91(4): 479–489.

    Article  CAS  PubMed  Google Scholar 

  9. Dejean LM, Martinez-Caballero S, Guo L, et al. Oligomeric, Bax Is a Component of the Putative, Cytochrome c Release Channel, MAC, Mitochondrial, Apoptosis-induced Channel. Mol Biol Cell 2005.

  10. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9(6): 691–704.

    Article  CAS  PubMed  Google Scholar 

  11. Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998; 17(19): 2515–2524.

    Article  CAS  PubMed  Google Scholar 

  12. Ahlemeyer B, Klumpp S, Krieglstein J. Release of cytochrome c into the extracellular space contributes to neuronal apoptosis induced by staurosporine. Brain Res 2002; 934(2): 107–116.

    Article  CAS  PubMed  Google Scholar 

  13. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144(5): 891–901.

    Article  CAS  PubMed  Google Scholar 

  14. Tafani M, Cohn JA, Karpinich NO, Rothman RJ, Russo MA, Farber JL. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha. J Biol Chem 2002; 277(51): 49569–49576.

    Article  CAS  PubMed  Google Scholar 

  15. Zhao RY, Bukrinsky M, Elder RT. HIV-1 Viral Protein R (Vpr) and Host Cellular Responses. Ind J Med Res 2005; 121(4): 270–286.

    CAS  Google Scholar 

  16. Zhao Y, Elder RT. Yeast perspectives on HIV-1 Vpr. Frontiers in Bioscience 2000; 5: 905–916.

    Google Scholar 

  17. Macreadie IG, Thorburn DR, Kirby DM, Castelli LA, de Rozario NL, Azad AA. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae. FEBS Lett 1997; 410(2–3): 145–149.

    Article  CAS  PubMed  Google Scholar 

  18. Macreadie IG, Castelli LA, Hewish DR, Kirkpatrick A, Ward AC, Azad AA. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci USA 1995; 92(7): 2770–2774.

    CAS  PubMed  Google Scholar 

  19. Zhao Y, Cao J, O'Gorman MRG, Yu M, Yogev R. Effect of human immunodeficiency virus Type 1 protein R (vpr) gene expression on basic cellular functions of fission yeast Schizosaccharomyces pombe. J Virol 1996; 70: 5821–5826.

    CAS  PubMed  Google Scholar 

  20. Zhao Y, Yu M, Chen M, Elder RT, Yamamoto AJC. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virol 1998a; 246: 266–276.

    Article  CAS  Google Scholar 

  21. Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virol 2001; 287(2): 359–370.

    Article  CAS  Google Scholar 

  22. Maundrell K. Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene 1993; 123(1): 127–130.

    Article  CAS  PubMed  Google Scholar 

  23. Zhao Y, Yu M, Chen M, Elder RT, Yamamoto A, Cao J. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virol 1998; 246: 266–276.

    Article  CAS  Google Scholar 

  24. Chen M, Elder RT, Yu M, et al. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol 1999; 73(4): 3236–3245.

    CAS  PubMed  Google Scholar 

  25. Zhao Y, Cao J, O'Gorman MRG, Yu M, Yogev R. Effect of human immunodeficiency virus Type 1 protein R (vpr) gene expression on basic cellular functions of fission yeast Schizosaccharomyces pombe. J Virol 1996; 70: 5821–5826.

    CAS  PubMed  Google Scholar 

  26. Zhao Y, Elder RT, Chen M, Cao J. Fission yeast expression vectors adapted for large scale cloning and GFP fusion with positive screening. BioTechniques 1998; 25: 438–444.

    CAS  PubMed  Google Scholar 

  27. Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology 2001; 287(2): 359–370.

    Article  CAS  PubMed  Google Scholar 

  28. Benko Z, Liang D, Agbottah E, et al. Anti-Vpr activity of a yeast chaperone protein. J Virol 2004; 78(20): 11016–11029.

    Article  CAS  PubMed  Google Scholar 

  29. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397(6718): 441–446.

    Article  CAS  PubMed  Google Scholar 

  30. Zhang S, Feng Y, Narayan O, Zhao L. Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP. Gene 2001; 263(1–2): 131–140.

    Article  CAS  PubMed  Google Scholar 

  31. Chowdhury IH, Wang XF, Landau NR, et al. HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. Virology 2003; 305(2): 371–377.

    Article  CAS  PubMed  Google Scholar 

  32. Amini S, Saunders M, Kelley K, Khalili K, Sawaya BE. Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem 2004; 279(44): 46046–46056.

    Article  CAS  PubMed  Google Scholar 

  33. Rebbaa A, Chou PM, Emran M, Mirkin BL. Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria. Cancer Chemother Pharmacol 2001; 48(6): 423–428.

    Article  CAS  PubMed  Google Scholar 

  34. Javelaud D, Besancon F. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio. J Biol Chem 2002; 277(40): 37949–37954.

    Article  CAS  PubMed  Google Scholar 

  35. Elder RT, Benko Z, Zhao Y. HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front Biosci 2002; 7: d349–d357.

    CAS  PubMed  Google Scholar 

  36. Zhao Y, Lieberman HB. Schizosaccharomyces pombe: A model for molecular studies of eukaryotic genes. DNA Cell Biol 1995; 14(5): 359–371.

    Article  CAS  PubMed  Google Scholar 

  37. Gogal RM, Jr., Smith BJ, Kalnitsky J, Holladay SD. Analysis of apoptosis of lymphoid cells in fish exposed to immunotoxic compounds. Cytometry 2000; 39(4): 310–318.

    Article  CAS  PubMed  Google Scholar 

  38. Muthumani K, Hwang DS, Desai BM, et al. HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem 2002; 277(40): 37820–37831.

    Article  CAS  PubMed  Google Scholar 

  39. Tafani M, Schneider TG, Pastorino JG, Farber JL. Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of the mitochondrial permeability transition. Am J Pathol 2000; 156(6): 2111–2121.

    CAS  PubMed  Google Scholar 

  40. Rhoads RE. Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 1999; 274(43): 30337–30340.

    Article  CAS  PubMed  Google Scholar 

  41. Ryazanov AG, Spirin AS. Phosphorylation of elongation factor 2: A key mechanism regulating gene expression in vertebrates. New Biol 1990; 2(10): 843–850.

    CAS  PubMed  Google Scholar 

  42. Ryazanov AG. Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett 2002; 514(1): 26–29.

    Article  CAS  PubMed  Google Scholar 

  43. Marin P, Nastiuk KL, Daniel N, et al. Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci 1997; 17(10): 3445–3454.

    CAS  PubMed  Google Scholar 

  44. Arora S, Yang JM, Kinzy TG, et al. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. Cancer Res 2003; 63(20): 6894–6899.

    CAS  PubMed  Google Scholar 

  45. Iglewski WJ. Cellular ADP-ribosylation of elongation factor 2. Mol Cell Biochem 1994; 138(1–2):131–133.

    Article  CAS  PubMed  Google Scholar 

  46. Iglewski BH, Liu PV, Kabat D. Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun 1977; 15(1): 138–144.

    CAS  PubMed  Google Scholar 

  47. Morimoto H, Bonavida B. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol 1992; 149(6): 2089–2094.

    CAS  PubMed  Google Scholar 

  48. Dorovkov MV, Pavur KS, Petrov AN, Ryazanov AG. Regulation of elongation factor-2 kinase by pH. Biochemistry 2002; 41(45): 13444–13450.

    Article  CAS  PubMed  Google Scholar 

  49. Feuermann M, Francisci S, Rinaldi T, et al. The yeast counterparts of human 'MELAS' mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu. EMBO Rep 2003; 4(1): 53–58.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Y. Zhao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zelivianski, S., Liang, D., Chen, M. et al. Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R. Apoptosis 11, 377–388 (2006). https://doi.org/10.1007/s10495-006-4030-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-006-4030-9

Keywords

Navigation